In conversation with Cristiana Campa: modernizing vaccine specifications and advancing risk-based quality frameworks
Abstract
Cristiana Campa examines how advances in analytical characterization and risk-based regulatory frameworks are redefining vaccine development and manufacturing. Drawing on her work revising the ICH Q6 guideline on specifications, she discusses the role of harmonized, science-driven standards in supporting vaccine quality, global development pathways, and emerging modalities such as therapeutic and mRNA-based vaccines.
Fields of Study & Subjects
Biosimilars and Bioanalytical Methods
Healthcare Regulation
Protein purification and stability
Publication details
- Journal / source
- Vaccine Insights
- Volume
- 5
- Issue
- 1
- Pages
- 35–37–35–37
- Publication date
- 13 February 2026
- Language
- EN